Alena Heimsoeth

Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Jana Fassunke, Fabienne Müller, Marina Keul et al. · Nature Communications · 2018 · 139 citations · Full text

Medicine, Oncology, Pharmacology +15

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

Johannes Brägelmann, Carina Lorenz, Sven Borchmann et al. · Nature Communications · 2021 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

SOX2 is essential for <i>in vivo</i> reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate

Daniel Nettersheim, Alena Heimsoeth, Sina Jostes et al. · Oncotarget · 2016 · 57 citations · Full text

Medicine, Developmental Biology, Oncology +17

Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S

Jonas Lategahn, Marina Keul, Philip Klövekorn et al. · Chemical Science · 2019 · 52 citations · Full text

Medicine, Oncology, Pharmacology +16

Functional synapses between neurons and small cell lung cancer

Vignesh Sakthivelu, Anna Schmitt, Franka Odenthal et al. · Nature · 2025 · 41 citations · Full text

Life Sciences, Neuroscience, Oncology +17